GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of help me understand half-life, I have read the wiki twice — 50 comments in the full submission. View in context.
3.5k
c/glp1science·submitted 2 years ago by u/employer_carveout

help me understand half-life, I have read the wiki twice

Speculationbranch of 8 comments

Asking properly rather than in a comment on somebody else’s thread: help me understand half-life, I have read the wiki twice. The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary. Started reading limitations sections first. It has changed how much weight I give to…

Read the full submission and all 50 comments →

This branch

8 comments, started 2 years ago
u/marisol_kravchenko0 points·2 years ago

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

replysharereportpermalink
u/nurse_ish_20251 point·2 years ago

Are we talking about receptor affinity or clinical potency?

replysharereportpermalink
u/devils_advocate_d1 point·2 years ago

mechanism explains a direction, not a magnitude

replysharereportpermalink
u/employer_carveoutOP1 point·2 years ago

glucagon agonism sounds paradoxical until you read the energy expenditure work

replysharereportpermalink
u/formulary_fighterappeals1 point·2 years ago

incretin effect first, then everything else in this board makes sense

replysharereportpermalink
u/yusuf_ramos1 point·2 years ago

Agreed — the incretin effect is the load-bearing concept and everything downstream reads differently once you have it.

replysharereportpermalink
[deleted]1 point·2 years ago

[deleted]

replysharereportpermalink
u/nadia_bakker1 point·2 years ago·edited

mechanism explains a direction, not a magnitude

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/glp1science
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/trialwatch_theou/gastric_emptying_gu/sig_figs_sam
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →